Topic summary
Donitriptan
Donitriptan (INN; developmental code name F-11356) is a triptandrug which was investigated as an antimigraine agent but was never marketed. It acts as a selectiveserotonin5-HT1B and 5-HT1D receptoragonist. The drug reached phase 2clinical trials prior to the discontinuation of its development.